reports robust phase 1b efficacy for ENV-294, a first-in-class oral therapy for atopic dermatitis

announces a $15M Series A to scale production of sustainable, low-cost construction materials

is pioneering a new type of AI hardware enabling intelligence at the boundaries of physics

our full report on the current market sentiment of leading climate investors representing over $20B in AUM

achieves unicorn status, announces oversubscribed $150M Series D and begins enrolling patients

highlights the incredible work our portfolio companies are doing to improve the health of people & planet

lands $65M from investors including Microsoft & Google to expand clean energy marketplace services

raises $100M Series A to build laser-driven nuclear fusion prototype system

announces a milestone $100M+ partnership with Regeneron to develop in-vivo CRISPR-based gene editing therapies